2008-09-05 20:05:02 -

www.researchandmarkets.com - Research and Markets (www.researchandmarkets.com/research/7cc759/5th_annual_report) has announced the addition of the "5th Annual Report Survey BioManufacturing Capacity" report to their offering.

There are an estimated 10,000 large molecule biotechnology medicines in preclinical discovery or clinical trials around the world today. Over 2,000 of these are in clinical development. These biotherapeutic

drugs target nearly 150 disease states and promise to bring better treatments to patients. However, if new biotherapeutics are to be made more accessible and affordable, most industry participants agree that improvements in performance and optimization of processes will be necessary. As the demand for production of biotherapeutics continues to grow, the question of whether current manufacturing capacity and production performance are sufficient to deal with the challenge becomes an important strategic issue.

Building new capacity and improving existing systems to meet the demand for new therapeutics, whether through in-house manufacturing or out-sourced contract manufacturing, has long-term cost implications. Designing new production facilities, bringing new capacity on line, and establishing new support services in these areas require accurate market knowledge, lead-time, large capital expenditures, and careful planning.

Both biopharmaceutical producers and contract manufacturers maintain a keen interest in the current and future status of industry capacity and trends. This report summarizes information obtained from worldwide biopharmaceutical manufacturers in late 2007. Its intent is to provide a quantitative assessment of industry capacity, production trends, and benchmarks. As an on-going benchmarking effort, it offers a view into current and future potential global industry bottlenecks.

This comprehensive look at the state of worldwide biopharmaceutical manufacturing provides the only on-going assessment of manufacturing capacity and production in this $80 billion global industry. You will find current, quantitative information from 434 worldwide biopharmaceutical developers and contract manufacturers, and over 120 suppliers to the industry. Covers year 2007.

Coverage includes:

-- In-depth analysis and summary of the key survey findings, trends and implications for industry-wide biomanufacturing capacity and biotherapeutic production

-- Comparison of production by biotherapeutic developers and contract manufacturing organizations

-- Current and future potential industry bottlenecks

-- Trend analysis in this 5th in a series of annual biopharmaceutical manufacturing industry evaluations

-- Projected capacity bottlenecks, and how they might be resolved

-- This edition includes the joint industry expertise from BioPlan Associates, and many industry consultants and experts

Key Topics Covered:

-- Introduction and Discussion

-- Demographics

-- Capacity Utilization

-- Current Capacity Constraints

-- Future Capacity Expansions

-- Disposables and Single-Use Systems in Biopharmaceutical Manufacturing

-- Downstream Purification

-- Quality Issues, Batch Failures, and PAT in Biopharmaceutical Manufacturing

-- Hiring, Employment Growth, and Training in Biopharmaceutical Manufacturing

-- Suppliers to Biopharmaceutical Manufacturing and Life Sciences

For more information visit www.researchandmarkets.com/research/7cc759/5th_annual_report

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
Fax (USA): 646-607-1907
Fax (International): +353-1-481-1716